AFP British drugs giant AstraZeneca on Wednesday agreed to sell part of its antibiotics business to US giant Pfizer for up to $1.6 billion (1.4 billion euros). The deal for the company’s small-molecule antibiotics, or those developed using traditional chemistry, is expected to complete in the fourth quarter, AstraZeneca said in a statement. The news comes days after Pfizer …
Read More »
The Gulf Time Newspaper One of the finest business newspapers in the UAE brought to you by our professional writers and editors.